How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients

被引:32
作者
Benezet, S
Guimbaud, R
Chatelut, E
Chevreau, C
Bugat, R
Canal, P
机构
[1] CTR CLAUDIUS REGAUD,F-31052 TOULOUSE,FRANCE
[2] UNIV TOULOUSE 3,F-31062 TOULOUSE,FRANCE
关键词
carboplatin; dose adaptation; ideal weight; obesity; pharmacokinetics;
D O I
10.1023/A:1008259009500
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. We previously proposed a formula to predict carboplatin clearance (CL) from four patient characteristics: plasma creatinine level, body weight: age, and sex (J Natl Cancer Inst 1995; 87: 573). Its accuracy was studied in a subpopulation of obese patients. Patients and methods. Twenty-five patients (16 male and 9 female, 23 to 82 years old) were studied. They were 20% to 67% (median 36%) over the ideal weight which was calculated according to the Lorentz equation. Their actual CL was obtained individually by the Siphar program. The pharmacokinetic population program NONMEM was used to determine the best value of substitution for weight in the formula. Results. By using the actual weight, CL was significantly overpredicted (by more than 20% for 7 of 25 patients). By using the mean value between the ideal and the actual weight, a good prediction of CL was obtained: the percentage of error ranged from -21% to +22%. Conclusion: The formula is applicable to obese patients if both ideal and actual weights are taken into account.
引用
收藏
页码:607 / 609
页数:3
相关论文
共 8 条
[1]  
BEAL SL, 1985, DRUG FATE METABOLISM, V5, P135
[2]  
CALVERT AH, 1995, SEMIN ONCOL, V22, P91
[3]   CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].
CALVERT, AH ;
NEWELL, DR ;
GUMBRELL, LA ;
OREILLY, S ;
BURNELL, M ;
BOXALL, FE ;
SIDDIK, ZH ;
JUDSON, IR ;
GORE, ME ;
WILTSHAW, E .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756
[4]   PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS [J].
CHATELUT, E ;
CANAL, P ;
BRUNNER, V ;
CHEVREAU, C ;
PUJOL, A ;
BONEU, A ;
ROCHE, H ;
HOUIN, G ;
BUGAT, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (08) :573-580
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]  
LORENTZ FH, 1929, KLIN WOCHENSCHR, V16, P734, DOI DOI 10.1007/BF01738018
[7]   VARIABLES AFFECTING CREATININE CLEARANCE PREDICTION [J].
SAWYER, WT ;
CANADAY, BR ;
POE, TE ;
WEBB, CE ;
GAL, P ;
JOYNER, PU ;
BERRY, JI .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (12) :2175-2180
[8]  
vanWarmerdam LJC, 1996, CANCER CHEMOTH PHARM, V37, P266